Continuing on with our discussion on strategies to help to protect against viruses in general and the SARS-CoV-2 virus in particular, today I want to highlight zinc.

As I have in previous posts, I want to make it clear that any of these recommendations I share are not intended to suggest that you should not access medical care if you suspect you may have contracted or been exposed to the SARS-CoV-2 virus – or any other serious illness.

Numerous clinical trials have clearly demonstrated that zinc is effective against viruses – including the common cold.

Some MDs have started to incorporate the use of zinc in a protocol which also includes Hydroxychloroquine – an old generation malaria drug with Azithromycin – an antibiotic.

In this anecdotal report from Vladimir (Zev) Zelenko MD who is based in Monroe, NY in his protocol he prescribed 200 mg of zinc sulfate per day for five days for active SARS-CoV-2 virus infections.

Typical zinc supplements are typically approximately 15 – 30 mg per day – this would be for ongoing health maintenance but not necessarily active viral infections.

Recent feedback has shown that the SARS-CoV-2 virus can initially become very active in the nose and throat areas and a zinc spray has traditionally been used for helping to target viral infections in these areas. Zinc sprays are often combined with other ingredients such as echinacea and they are available at most health food stores.

One consideration with respect to zinc consumption is that you need to be careful because there is a balance in the body between zinc and copper.

Some zinc supplements also include added copper – typically approximately 2 mg per day.

Consult a knowledgeable health care practitioner for more precise information on recommended dosages.

Zinc is another compound that we have available to help to maintain our state of health and to help to prevent viral infections – but also it can be a valuable tool for active infections.

Leave a Reply

Your email address will not be published. Required fields are marked *